SCHEMBL4444690

SCHEMBL4444690

CC(C)(C)[Si](C)(C)OC1CCNCC1N(C(=O)O)c1ccncc1NC(=O)c1nc(Br)c(F)cc1N

nearest known ligand 0.37

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PIM3 Q86V86 19/20 0.37
PIM2 Q9P1W9 19/20 0.37
PIM1 P11309 18/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4439852 0.94 PIM3 (0.37) PIM3PIM2PIM1
SCHEMBL4438383 0.89 PIM2 (0.34) PIM3PIM2PIM1
SCHEMBL4437099 0.89 PIM2 (0.34) PIM3PIM2PIM1
SCHEMBL4437200 0.88 PIM1 (0.38) PIM3PIM2PIM1
SCHEMBL4435474 0.86 PIM2 (0.49) PIM3PIM2PIM1
SCHEMBL4434926 0.83 PIM2 (0.34) PIM3PIM2PIM1
SCHEMBL3411675 0.81 PIM1 (0.40) PIM3PIM2PIM1
SCHEMBL3411679 0.81 PIM1 (0.40) PIM3PIM2PIM1
SCHEMBL1710369 0.80 KDM4E (0.32)
SCHEMBL3228821 0.80 KDM4E (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2132177-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE Novartis Ag (CH) 2009-12-16 EP disclosed
WO-2008106692-A1 PIM KINASE INHIBITORS AND METHODS OF THEIR USE NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) 2008-09-04 WO disclosed